Earnings (Loss) Per Share (Tables)

12 Months Ended

Feb. 28, 2025

Schedule of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings (loss) per share:


	For the Years Ended
	February 28, 2025		February 29, 2024		February 28, 2023
Net income (loss) from continuing operations for basic and diluted earnings (loss) per share available to common shareholders	$	(8.5)	$	5.6	$	(215.5)
Less: Debentures fair value adjustment (1) (2)	—		—		(137.4)
Add: interest expense on Debentures (1) (2)	—		—		6.4
Net income (loss) from continuing operations for diluted earnings (loss) per share available to common shareholders	$	(8.5)	$	5.6	$	(346.5)

Net loss for basic and diluted loss per share available to common shareholders	(79.0)		(130.2)		(734.4)
Less: Debentures fair value adjustment (1) (2)	—		—		(137.4)
Add: interest expense on Debentures (1) (2)	—		—		6.4
Net loss for diluted loss per share available to common shareholders	$	(79.0)	$	(130.2)	$	(865.4)

Weighted average number of shares outstanding (000’s) - basic	591,470		584,543		578,654
Effect of dilutive securities (000’s)
Stock-based compensation (3) (4)	—		7,954		—
Conversion of 2020 Debentures (1) (2)	—		—		60,833

Weighted average number of shares and assumed conversions (000’s) diluted	591,470		592,497		639,487
Earnings (loss) per share - reported
Basic earnings (loss) per share from continuing operations	$	(0.01)	$	0.01	$	(0.37)
Total basic loss per share	$	(0.13)	$	(0.22)	$	(1.27)

Diluted earnings (loss) per share from continuing operations	$	(0.01)	$	0.01	$	(0.54)
Total diluted loss per share	$	(0.13)	$	(0.22)	$	(1.35)

______________________________

(1) The Company has not presented the dilutive effect of the Debentures using the if-converted method in the calculation of diluted loss per share for the years ended February 28, 2025 and February 29, 2024, as to do so would be antidilutive. See Note 7 for details on the Debentures.

(2) The Company has presented the dilutive effect of the 2020 Debentures using the if-converted method, assuming conversion at the beginning of the fiscal year for the year ended February 28, 2023. Accordingly, to calculate diluted loss per share, the Company adjusted net income (loss) by eliminating the fair value adjustment made to the 2020 Debentures and interest expense incurred on the 2020 Debentures in the year ended February 28, 2023, and added the number of shares that would have been issued upon conversion to the diluted weighted average number of shares outstanding. See Note 7 for details on the 2020 Debentures.

(3) The Company has not presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the years ended February 28, 2025 and February 28, 2023 as to do so would be antidilutive.

(4) The Company has presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the year ended February 29, 2024